Home › Linfoma di Burkitt › California › Orange
Studi clinici su Linfoma di Burkitt a Orange, CA
9 studi su Linfoma di Burkitt cercano partecipanti presso sedi a Orange e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
In reclutamentoFase 2
- Children's Hospital of Orange County, Orange
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
In reclutamentoFase 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
In reclutamentoFase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
In reclutamentoFase 2
- Children's Hospital of Orange County, Orange
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
In reclutamentoFase 3
- UC Irvine, Orange
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
In reclutamentoFase 2
- Children's Hospital of Orange County, Orange
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
In reclutamentoFase 3
- Children's Hospital of Orange County, Orange
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
In reclutamentoFase 2
- Children's Hospital Orange County, Orange
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
In reclutamentoFase 1/2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Studi su Linfoma di Burkitt in altre città
- Houston, TX21 studi
- Milwaukee, WI16 studi
- Philadelphia, PA16 studi
- New York City, NY14 studi
- Chicago, IL14 studi
- Cincinnati, OH12 studi
- Atlanta, GA12 studi
- Seattle, WA11 studi
- Durham, NC10 studi
- Boston, MA10 studi
- Los Angeles, CA10 studi
- Aurora, CO10 studi
Altri studi a Orange
- Cancro del polmone non a piccole cellule25 studi
- Cancro metastatico20 studi
- Cancro colorettale16 studi
- Cancro ovarico16 studi
- Cancro pancreatico15 studi
- Cancro al seno14 studi
- Cancro ai polmoni14 studi
- Cancro alla prostata14 studi
- Cancro al fegato (carcinoma epatocellulare)14 studi
- Melanoma14 studi
- Leucemia mieloide acuta13 studi
- Cancro (tutti i tipi)13 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.